… n the metabolite of metronidazole. The clinical significance of this is not known at present. However in patients undergoing haemodialysis, metronidazole and its metabolites are efficiently removed.
Contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) and ethyl parahydroxybenzoate (E214), may cause allergic reactions (possibly delayed).
… d prolonged use of this medication should be avoided.
Evidence suggests that metronidazole is carcinogenic in certain animal species. There is no evidence to date of a carcinogenic effect in human.
This product contains 50 mg of propylene glycol (E1520) in each gram which is equivalent to 5% w/w and may cause skin irritation. This product also contains hydroxybenzoic acid esters which may cause allergic reactions (possibly delayed) and bronopol which may cause local skin reactions (e.g. contact dermatitis).